A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter - PubMed (original) (raw)
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
G Melillo et al. J Exp Med. 1995.
Abstract
Picolinic acid, a catabolite of L-tryptophan, activates the transcription of the inducible nitric oxide synthase gene (iNOS) in IFN-gamma-treated murine macrophages. We performed functional studies on the 5' flanking region of the iNOS gene linked to a CAT reporter gene to identify the cis-acting element(s) responsible for the activation of iNOS transcription by picolinic acid. Transient transfection assays showed that the full-length iNOS promoter in the murine macrophage cell line ANA-1 was activated by the synergistic interaction between IFN-gamma and picolinic acid. Deletion or mutation of the iNOS promoter region from -227 to -209, containing a sequence homology to a hypoxia-responsive enhancer (iNOS-HRE), decreased picolinic acid- but not LPS-induced CAT activity by more than 70%. Functional studies using a tk promoter-CAT reporter gene plasmid demonstrated that the iNOS-HRE was sufficient to confer inducibility by picolinic acid but not by IFN-gamma or LPS. Electrophoretic mobility shift assays confirmed that picolinic acid alone induced a specific binding activity to the iNOS-HRE. Furthermore, we found that the iNOS-HRE activity was inducible by hypoxia and that hypoxia in combination with IFN-gamma activated the iNOS promoter in transient transfection assays and induced iNOS transcription and mRNA expression. These data establish that the iNOS-HRE is a novel regulatory element of the iNOS promoter activity in murine macrophages and provide the first evidence that iNOS is a hypoxia-inducible gene.
Similar articles
- Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine.
Melillo G, Taylor LS, Brooks A, Musso T, Cox GW, Varesio L. Melillo G, et al. J Biol Chem. 1997 May 2;272(18):12236-43. doi: 10.1074/jbc.272.18.12236. J Biol Chem. 1997. PMID: 9115299 - Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine.
Weisz A, Cicatiello L, Esumi H. Weisz A, et al. Biochem J. 1996 May 15;316 ( Pt 1)(Pt 1):209-15. doi: 10.1042/bj3160209. Biochem J. 1996. PMID: 8645207 Free PMC article. - Regulation of inducible nitric oxide synthase expression in IFN-gamma-treated murine macrophages cultured under hypoxic conditions.
Melillo G, Taylor LS, Brooks A, Cox GW, Varesio L. Melillo G, et al. J Immunol. 1996 Sep 15;157(6):2638-44. J Immunol. 1996. PMID: 8805668 - Immunobiology of picolinic acid.
Melillo G, Bosco MC, Musso T, Varesio L. Melillo G, et al. Adv Exp Med Biol. 1996;398:135-41. doi: 10.1007/978-1-4613-0381-7_22. Adv Exp Med Biol. 1996. PMID: 8906256 Review. No abstract available. - Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene.
Taylor BS, Geller DA. Taylor BS, et al. Shock. 2000 Jun;13(6):413-24. doi: 10.1097/00024382-200006000-00001. Shock. 2000. PMID: 10847627 Review.
Cited by
- Low dimensional nanomaterials for treating acute kidney injury.
Nie Y, Wang L, You X, Wang X, Wu J, Zheng Z. Nie Y, et al. J Nanobiotechnology. 2022 Dec 1;20(1):505. doi: 10.1186/s12951-022-01712-2. J Nanobiotechnology. 2022. PMID: 36456976 Free PMC article. Review. - Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
Burroughs SK, Kaluz S, Wang D, Wang K, Van Meir EG, Wang B. Burroughs SK, et al. Future Med Chem. 2013 Apr;5(5):553-72. doi: 10.4155/fmc.13.17. Future Med Chem. 2013. PMID: 23573973 Free PMC article. Review. - Hypergravity upregulates renal inducible nitric oxide synthase expression and nitric oxide production.
Yoon G, Oh CS, Kim HS. Yoon G, et al. Oncotarget. 2016 May 24;7(21):30147-54. doi: 10.18632/oncotarget.9253. Oncotarget. 2016. PMID: 27174912 Free PMC article. - Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions.
Chen Z, Han F, Du Y, Shi H, Zhou W. Chen Z, et al. Signal Transduct Target Ther. 2023 Feb 17;8(1):70. doi: 10.1038/s41392-023-01332-8. Signal Transduct Target Ther. 2023. PMID: 36797231 Free PMC article. Review. - Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.
Takeda N, O'Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, Asagiri M, Simon MC, Hoffmann A, Johnson RS. Takeda N, et al. Genes Dev. 2010 Mar 1;24(5):491-501. doi: 10.1101/gad.1881410. Genes Dev. 2010. PMID: 20194441 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6338-42 - PubMed
- Cell. 1994 Sep 23;78(6):915-8 - PubMed
- J Biol Chem. 1991 Aug 25;266(24):15563-6 - PubMed
- J Immunol. 1991 Dec 1;147(11):3809-14 - PubMed
- Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10553-7 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous